Expert Speaks on Genetic Data Revealing Patients' Drug Treatment Response When: October 6, 2004 Where: Masur Auditorium, Bethesda, MD Institute: National Institute on Deafness and Other Communication Disorders (NIDCD) People interested in hearing more about how genetic information can predict patients' response to drug treatments, as well as how such information can be used in creating new drugs and diagnostic tests, can hear an expert address given on these issues. David Cox, M.D., Ph.D., Chief Scientific Officer of Perlegen Sciences, Inc., delivered the NIH Director's Wednesday Afternoon Lecture Series talk, entitled "Human Genetic Variation and Common Diseases: A Short Term Approach for Improving Human Health."
The lecture was sponsored by the NIDCD. The NIH Director's Wednesday Afternoon Lecture Series invites experts nominated by researchers and scientific interest groups throughout NIH, and approved by the NIH Director. Next Steps The lecture can be heard on webcast at http://videocast.nih.gov. For more information, contact Hilda Madine at (301) 594-5595. For more information on the NIH Director's Wednesday Afternoon Lecture Series, visit http://www1.od.nih.gov/wals/schedule.htm.
|